Neuroprotective effects of geneticin (G418) via apoptosisin perinatal hypoxic-ischemic brain injury

다국어 초록 (Multilingual Abstract)

Purpose:Some antibiotics were known to exert neuroprotective effects in the animal model of hypoxic-ischemic (H-I) brain injury, but the mechanism is still unclear. A recent study reported that geneticin (G418), an aminoglycoside antibiotic, increased survival of human breast cancer cells by suppressing apoptosis. We investigated the neuroprotective effects of systemically administrated geneticin via anti-apoptosis following the H-I brain injury
Methods:Seven-day-old Sprague-Dawley rat pups were subjected to unilateral (left) common carotid artery occlusion followed by 2.5 hours of hypoxic exposure and the cortical cell culture of rat brain was done under a hypoxic incubator. Apoptosis was measured in the injured hemispheres 7 days after H-I insult and in the injured cells from hypoxic chamber using morphologic analysis by Terminal dUTP Nick-end Labeling(TUNEL) assay and immunohistochemistry for caspase-3, and cytologic analysis by western blot and real time PCR for bax, bcl-2, and caspase-3.
Results:The gross appearance and hematoxylin and eosin stain revealed increased brain volume in the geneticin-treated animal model of perinatal H-I brain injury. The TUNEL assay revealed decreased apoptotic cells after administration of geneticin in the cell culture model of anoxia. Immunohistochemistry showed decreased caspase-3 expression in geneticin-treated cortical cell culture. Western blot and real-time PCR showed decreased caspase-3 expression and decreased ratio of Bax/ Bcl-2 expression in geneticin-treated animal model.
Conclusion:Geneticin appears to exert a neuroprotective effect against perinatal H-I brain injury at least via anti-apoptosis. However, more experiments are needed in order to demonstrate the usefulness of geneticin as a preventive and rescue treatment for H-I brain injuries of neonatal brain. (Korean J Pediatr 2008;51:170-180)

다국어 초록 (Multilingual Abstract)

Purpose:Some antibiotics were known to exert neuroprotective effects in the animal model of hypoxic-ischemic (H-I) brain injury, but the mechanism is still unclear. A recent study reported that geneticin (G418), an aminoglycoside antibiotic, increased survival of human breast cancer cells by suppressing apoptosis. We investigated the neuroprotective effects of systemically administrated geneticin via anti-apoptosis following the H-I brain injury
Methods:Seven-day-old Sprague-Dawley rat pups were subjected to unilateral (left) common carotid artery occlusion followed by 2.5 hours of hypoxic exposure and the cortical cell culture of rat brain was done under a hypoxic incubator. Apoptosis was measured in the injured hemispheres 7 days after H-I insult and in the injured cells from hypoxic chamber using morphologic analysis by Terminal dUTP Nick-end Labeling(TUNEL) assay and immunohistochemistry for caspase-3, and cytologic analysis by western blot and real time PCR for bax, bcl-2, and caspase-3.
Results:The gross appearance and hematoxylin and eosin stain revealed increased brain volume in the geneticin-treated animal model of perinatal H-I brain injury. The TUNEL assay revealed decreased apoptotic cells after administration of geneticin in the cell culture model of anoxia. Immunohistochemistry showed decreased caspase-3 expression in geneticin-treated cortical cell culture. Western blot and real-time PCR showed decreased caspase-3 expression and decreased ratio of Bax/ Bcl-2 expression in geneticin-treated animal model.
Conclusion:Geneticin appears to exert a neuroprotective effect against perinatal H-I brain injury at least via anti-apoptosis. However, more experiments are needed in order to demonstrate the usefulness of geneticin as a preventive and rescue treatment for H-I brain injuries of neonatal brain. (Korean J Pediatr 2008;51:170-180)

참고문헌 (Reference)

• 1 Williams CE, "Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep" 22 : 516-521, 1991
• 2 Chen Y, "The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells" 21 : 34-40, 2001
• 3 Rice JE, "The influence of immaturity on hypoxic-ischemic brain damage in the rat" 9 : 131-141, 1981
• 4 Lee TS, "The effect of Geneticin on the survival of a human breast cancer cells under hypoxic condition" 5 : 279-283, 2002
• 5 Coggan JS, "The aminiglycoside G418 suppresses muscarinic receptor-activated calcium release in stably transfected murine N1E-115 neuroblastoma cells" 11 : 247-250, 1994
• 6 Yrjanheikki J, "Tetracycline Inhibit Microglial Activation and Are Neuroprotective in Global Brain Ischemia" 22 : 15769-15774, 1998
• 7 Tikka T, "Tetracycline Derivatives and Ceftriaxone, A Cephalosporin Antibiotic, Protect Neurons Against Apoptosis Induced by Ionizing Radiation" 78 : 1409-1414, 2001
• 8 Yin W, "TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF" 21 : 358-371, 2006
• 9 White A, "Systemic review of therapy after hypoxic-ischaemic brain injury in the perinatal period" 5 : 33-40, 2000
• 10 Han BH, "Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury" 277 : 30128-30136, 2002
• 11 Clark WM, "Reduction of Central Nervous System Reperfusion Injury in Rabbits Using Doxycycline treatment" 25 : 1411-1415, 1994
• 12 Vannucci RC, "Rat model of perinatal hypoxic-ischemic brain damage" 55 : 158-163, 1999
• 13 Ishida A, "Prolonged suppression of brain nitric oxide synthase activity by 7- nitroindazole pretects against cerebral hypoxic-ischemic injury in neonatal rat" 23 : 349-354, 2001
• 14 Thoresen M, "Post-hypoxic cooling of neonatal rats provides protection against brain injury" 74 : F3-F9, 1996
• 15 McDonald JW, "Physiological and pathophysiological roles of excitatory amino acids during central nervous system development" 15 : 41-70, 1990
• 16 Vannucci RC, "Perinatal hypoxic-ischemic brain damage: evolution of an animal model" 27 : 81-86, 2005
• 17 Volpe JJ, "Perinatal brain injury: from pathogenesis to neuroprotection" 7 : 56-64, 2001
• 18 Weitzdoerfer R, "Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior" 28 : 249-256, 2004
• 19 Calvert JW, "Pathophysiology of an hypoxic-ischemic insult during the perinatal period" 27 : 246-260, 2005
• 20 Yasuoka N, "Neuroprotection of Edaravone on hypoxic-ischemia brain injury in neonatal rats" 19 : 129-139, 2004
• 21 Arvin KL, "Minocycline Markedly Protects the Neonatal Brain Against Hypoxic-Ischemia Injury" 52 : 54-61, 2002
• 22 Banasiak KJ, "Mechanisms underlying hypoxia-induced neuronal apoptosis" 62 : 215-249, 2000
• 23 Eustice DC, "Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis" 26 : 53-60, 1984
• 24 Turkyilmaz C, "Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia" 15 : 133-137, 2002
• 25 Brewer GJ, "Isolation and culture of adult rat hippocampal neurons" 71 : 143-155, 1997
• 26 Vannucci RC, "Interventions for perinatal hypoxic-ischemic encephalopathy" 100 : 1004-1014, 1997
• 27 Johnston BM, "Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs" 97 : 300-308, 1996
• 28 Vannucci RC, "Hypoxic-ischemic encephalopathy" 17 : 113-120, 2000
• 29 Vannucci RC, "Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage" 27 : 317-326, 1990
• 30 Northington FJ, "Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis" 8 : 207-219, 2001
• 31 Jantzie LL, "Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia" 25 : 314-324, 2005
• 32 Hill IE, "DNA fragmentaion indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat" 676 : 398-403, 1995
• 33 Schwartzman RA, "Apoptosis: the biochemistry and molecular biology of programmed cell death" 14 : 133-151, 1993
• 34 Nakajima W, "Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat" 20 : 7994-8004, 2000
• 35 Loebenberg D, "Antibiotic G-418, a New Micromonospora-Produced Aminoglycoside with Activity Against Protozoa and Helminths" 7 : 811-815, 1975
• 36 Levine S, "Anoxic-ischemic encephalopathy in rats" 6 : 1-17, 1960
• 37 Yrjanheikki J, "A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window" 96 : 13496-13500, 1999